Coordinated Regulation of Hepatic Phase I and II Drug-Metabolizing Genes and Transporters using AhR-, CAR-, PXR-, PPARα-, and Nrf2-Null Mice

The transcription factors aryl hydrocarbon receptor (AhR), constitutive androstane receptor (CAR), pregnane X receptor (PXR), peroxisome proliferator-activated receptor α (PPARα), and nuclear factor erythroid 2-related factor 2 (Nrf2) regulate genes encoding drug-metabolizing enzymes and transporters in livers of mice after chemical activation. However, the specificity of their transcriptional regulation has not been determined systematically in vivo. The purpose of this study was to identify genes encoding drug-metabolizing enzymes and transporters altered by chemical activators in a transcription factor-dependent manner using wild-type and transcription factor-null mice. Chemical activators were administered intraperitoneally to mice once daily for 4 days. Livers were collected 24 h after the final dose, and total RNA was isolated for mRNA quantification of cytochromes P450, NAD(P)H quinone oxidoreductase 1 (Nqo1), aldehyde dehydrogenases (Aldhs), glutathione transferases (Gsts), sulfotransferases (Sults), UDP-glucuronosyltransferases (Ugts), organic anion-transporting polypeptides (Oatps), and multidrug resistance-associated proteins (Mrps). Pharmacological activation of each transcription factor leads to mRNA induction of drug metabolic and transport genes in livers of male and female wild-type mice, but no change in null mice: AhR (Cyp1a2, Nqo1, Aldh7a1, Ugt1a1, Ugt1a6, Ugt1a9, Ugt2b35, Sult5a1, Gstm3, and Mrp4), CAR (Cyp2b10, Aldh1a1, Aldh1a7, Ugt1a1, Ugt2b34, Sult1e1, Sult3a1, Sult5a1, Papps2, Gstt1, Gsta1, Gsta4, Gstm1–4, and Mrp2–4), PXR (Cyp3a11, Ugt1a1, Ugt1a5, Ugt1a9, Gsta1, Gstm1–m3, Oatp1a4, and Mrp3), PPARα (Cyp4a14, Aldh1a1, mGst3, Gstm4, and Mrp4), and Nrf2 (Nqo1, Aldh1a1, Gsta1, Gsta4, Gstm1–m4, mGst3, and Mrp3–4). Taken together, these data reveal transcription factor specificity and overlap in regulating hepatic drug disposition genes by chemical activators. Coordinated regulation of phase I, phase II, and transport genes by activators of transcription factors can have implications in development of pharmaceuticals as well as risk assessment of environmental contaminants.

[1]  C. Klaassen,et al.  Mechanisms of gender-specific regulation of mouse sulfotransferases (Sults) , 2011, Xenobiotica; the fate of foreign compounds in biological systems.

[2]  David M. Reif,et al.  Xenobiotic-Metabolizing Enzyme and Transporter Gene Expression in Primary Cultures of Human Hepatocytes Modulated by Toxcast Chemicals , 2010, Journal of toxicology and environmental health. Part B, Critical reviews.

[3]  Curtis D. Klaassen,et al.  Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation , 2010, Pharmacological Reviews.

[4]  Robert J Kavlock,et al.  Impact of environmental chemicals on key transcription regulators and correlation to toxicity end points within EPA's ToxCast program. , 2010, Chemical research in toxicology.

[5]  C. Klaassen,et al.  Introducing the "TCDD-inducible AhR-Nrf2 gene battery". , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[6]  C. Klaassen,et al.  Application of multivariate statistical procedures to identify transcription factors that correlate with MRP2, 3, and 4 mRNA in adult human livers , 2009, Xenobiotica; the fate of foreign compounds in biological systems.

[7]  C. Klaassen,et al.  Mechanism of Gender-Divergent UDP-Glucuronosyltransferase mRNA Expression in Mouse Liver and Kidney , 2009, Drug Metabolism and Disposition.

[8]  C. Klaassen,et al.  Induction of Mouse UDP-Glucuronosyltransferase mRNA Expression in Liver and Intestine by Activators of Aryl-Hydrocarbon Receptor, Constitutive Androstane Receptor, Pregnane X Receptor, Peroxisome Proliferator-Activated Receptor α, and Nuclear Factor Erythroid 2-Related Factor 2 , 2009, Drug Metabolism and Disposition.

[9]  K. Bock,et al.  Coordinate regulation of human drug-metabolizing enzymes, and conjugate transporters by the Ah receptor, pregnane X receptor and constitutive androstane receptor. , 2009, Biochemical pharmacology.

[10]  C. Handschin,et al.  Induction of drug metabolism: the role of nuclear receptors. , 2008, Pharmacological reviews.

[11]  S. Choudhuri,et al.  Induction of hepatic glutathione S-transferases in male mice by prototypes of various classes of microsomal enzyme inducers. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[12]  J. Peters,et al.  Nrf2- and PPAR alpha-mediated regulation of hepatic Mrp transporters after exposure to perfluorooctanoic acid and perfluorodecanoic acid. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[13]  Jonathan P. Jackson,et al.  The Nrf2 Activator Oltipraz Also Activates the Constitutive Androstane Receptor , 2008, Drug Metabolism and Disposition.

[14]  C. Klaassen,et al.  Regulation of Sulfotransferase Enzymes by Prototypical Microsomal Enzyme Inducers in Mice , 2008, Journal of Pharmacology and Experimental Therapeutics.

[15]  Masayuki Yamamoto,et al.  Oxidative and electrophilic stress induces multidrug resistance–associated protein transporters via the nuclear factor‐E2–related factor‐2 transcriptional pathway , 2007, Hepatology.

[16]  J. Petrick,et al.  Importance of Hepatic Induction of Constitutive Androstane Receptor and Other Transcription Factors That Regulate Xenobiotic Metabolism and Transport , 2007, Drug Metabolism and Disposition.

[17]  J. Manautou,et al.  Emerging Role of Nrf2 in Protecting Against Hepatic and Gastrointestinal Disease , 2007, Toxicologic pathology.

[18]  Xingguo Cheng,et al.  Regulation of mRNA Expression of Xenobiotic Transporters by the Pregnane X Receptor in Mouse Liver, Kidney, and Intestine , 2006, Drug Metabolism and Disposition.

[19]  C. Klaassen,et al.  Tissue distribution and ontogeny of sulfotransferase enzymes in mice. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[20]  Olivier Fardel,et al.  Differential Regulation of Sinusoidal and Canalicular Hepatic Drug Transporter Expression by Xenobiotics Activating Drug-Sensing Receptors in Primary Human Hepatocytes , 2006, Drug Metabolism and Disposition.

[21]  D. Moore,et al.  trans-Stilbene Oxide Induces Expression of Genes Involved in Metabolism and Transport in Mouse Liver via CAR and Nrf2 Transcription Factors , 2006, Molecular Pharmacology.

[22]  Jeffrey S Moffit,et al.  Induction of Hepatic Transporters Multidrug Resistance-Associated Proteins (Mrp) 3 and 4 by Clofibrate Is Regulated by Peroxisome Proliferator-Activated Receptor α , 2006, Journal of Pharmacology and Experimental Therapeutics.

[23]  Xingguo Cheng,et al.  REGULATION OF MOUSE ORGANIC ANION-TRANSPORTING POLYPEPTIDES (OATPS) IN LIVER BY PROTOTYPICAL MICROSOMAL ENZYME INDUCERS THAT ACTIVATE DISTINCT TRANSCRIPTION FACTOR PATHWAYS , 2005, Drug Metabolism and Disposition.

[24]  K. Zatloukal,et al.  CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice , 2005, Hepatology.

[25]  C. Klaassen,et al.  Regulation of hepatic transporters by xenobiotic receptors. , 2005, Current drug metabolism.

[26]  Curtis D. Klaassen,et al.  INDUCTION OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN FAMILY OF TRANSPORTERS BY CHEMICAL ACTIVATORS OF RECEPTOR-MEDIATED PATHWAYS IN MOUSE LIVER , 2005, Drug Metabolism and Disposition.

[27]  A. Kong,et al.  Induction of phase I, II and III drug metabolism/transport by xenobiotics , 2005, Archives of pharmacal research.

[28]  Hongbing Wang,et al.  Transcriptional regulation of cytochrome p450 2B genes by nuclear receptors. , 2003, Current drug metabolism.

[29]  K. Itoh,et al.  Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence. , 2003, The Biochemical journal.

[30]  Y. Liu,et al.  Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[31]  J. Auwerx,et al.  Peroxisome Proliferator-activated Receptor-α Regulates Lipid Homeostasis, but Is Not Associated with Obesity , 2001, The Journal of Biological Chemistry.

[32]  T. Willson,et al.  The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. Jaiswal,et al.  Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Y. Kan,et al.  NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[35]  K. Griffin,et al.  Role of the peroxisome proliferator‐activated receptor in cytochrome P450 4A gene regulation , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  J. Reddy,et al.  Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[37]  T. Pineau,et al.  Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators , 1995, Molecular and cellular biology.

[38]  J. Whitlock,et al.  Induction of hepatic cytochrome P450 gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 1989, Molecular biology & medicine.

[39]  C. Klaassen.  Effect of Microsomal Enzyme Inducers on the Biliary Excretion of an Exogenous Load of Bilirubin in Newborn Rats 1 , 1976, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[40]  C. Klaassen.  Effect of microsomal enzyme inducers on the biliary excretion of cardiac glycosides. , 1974, The Journal of pharmacology and experimental therapeutics.

[41]  C. Klaassen.  Plasma disappearance and biliary excretion of sulfobromophthalein and phenol-3,6-dibromphthalein disulfonate after microsomal enzyme induction. , 1970, Biochemical pharmacology.

[42]  C. Klaassen,et al.  Tissue distribution, ontogeny, and regulation of aldehyde dehydrogenase (Aldh) enzymes mRNA by prototypical microsomal enzyme inducers in mice. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[43]  S. Wrighton,et al.  An assessment of udp-glucuronosyltransferase induction using primary human hepatocytes. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[44]  J. Lehmann,et al.  Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital. , 2002, Molecular pharmacology.

[45]  A. Mahfoudi,et al.  Positive regulation of the peroxisomal β‐oxidation pathway by fatty acids through activation of peroxisome proliferator‐activated receptors (PPAR) , 1993, Biology of the cell.